Stuart Nancy

CIK 0001594774

Chief Operating OfficerDirector

Filings

Latest Oct 2, 2025

Issuers covered

Showing

10 of 10

Page 1

Track record

Realized signed returns on open-market buys and sales

No scored trades yet for Stuart Nancy. Track record appears once open-market purchases or sales reach the +30 day horizon.

Companies where Stuart Nancy has filed

Ticker	Issuer	Filings	Last filed
CNCE	Concert Pharmaceuticals, Inc.	7	Mar 6, 2023
KALV	Kalvista Pharmaceuticals, Inc.	3	Oct 2, 2025

10 Form 4 / 4-A filings, newest first

Filed	Issuer	Top transaction	Shares	Price	Value
Oct 2, 2025	KALVKalvista Pharmaceuticals, Inc.	Holdings only	-	-	-
Oct 4, 2024	KALVKalvista Pharmaceuticals, Inc.	Holdings only	-	-	-
Sep 28, 2023	KALVKalvista Pharmaceuticals, Inc.	Holdings only	-	-	-
Mar 6, 2023	CNCEConcert Pharmaceuticals, Inc.	DDisposition	73,233	-	-
Feb 16, 2023	CNCEConcert Pharmaceuticals, Inc.	SSale	6,048	$8.33	$50,380
Jan 31, 2023	CNCEConcert Pharmaceuticals, Inc.	SSale	13,200	$8.35	$110,220
Jan 9, 2023	CNCEConcert Pharmaceuticals, Inc.	SSale	2,893	$7.25	$20,974
Feb 16, 2022	CNCEConcert Pharmaceuticals, Inc.	SSale	6,049	$3.08	$18,631
Feb 1, 2022	CNCEConcert Pharmaceuticals, Inc.	AGrant	99,000	-	-
Jan 7, 2022	CNCEConcert Pharmaceuticals, Inc.	SSale	2,894	$3.19	$9,232

Showing 1-10 of 10

Page 1 of 1

Real-time Form 4 intelligence. Smarter insider tracking.